FDA greenlights Lupin's generic hypertension drug

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The FDA has authorized perindopril erbumine in 2 mg, 4 mg, and 8 mg tablets from generic pharmaceutical maker Lupin Pharmaceuticals for use in patients with essential hypertension and as a conventional treatment for the management of coronary artery disease.

According to Mumbai, India-based Lupin, the drug is AB-rated to Aceon (perindopril erbumine; Solvay Pharmaceuticals), which net sales reached $24 million in 2009.